Search

MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Go inside the lab of Tuomas Tammela from SKI’s Cancer Biology & Genetics Program.

Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.